More than two years after a…
More than two years after a positive topline readout, AstraZeneca [...]
More than two years after a positive topline readout, AstraZeneca [...]
Merck offered a closer look at Keytruda’s overall survival benefits [...]
The FDA has endorsed Amgen and AstraZeneca’s Tezspire as an [...]
Xoma Royalty and Lava Therapeutics are turning the temperature down, [...]
For the second year running, Pfizer has arrived at the [...]
Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, [...]
Danish vaccine developer Evaxion has released long-term data for its [...]
Roche’s giredestrant was shown to reduce the risk of breast [...]
For the second time, Astellas is walking away from Taysha [...]
The president unveiled several policy proposals on Thursday aimed at [...]